ADVFN ADVFN

Hot Features

Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Bolt Biotherapeutics Inc

Bolt Biotherapeutics Inc (BOLT)

4.43
-0.19
(-4.11%)
終了 6月11日 5:00AM
4.43
0.00
(0.00%)
取引時間後: 5:01AM

Bolt Biotherapeutics Inc (BOLT) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
4.43
( -4.11% )
買値
4.28
売値
5.04
出来高
11,482
4.43 日の範囲 4.612
3.91 52 週間の範囲 7.35
時価総額
前日終値
4.62
始値
4.61
時刻
1
@
4.42
最終取引時間
財務取引量
US$ 51,811
VWAP
4.5124
平均取引量 (3 か月)
US$ 24,749
発行済株式数
1,921,567
配当利回り
PER
-0.28
1 株当たり利益 (EPS)
-16.34
歳入
6.5M
純利益
-29.58M

Bolt Biotherapeutics Inc について

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company’s pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/ga... Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company’s pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; CEA ISAC, a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5 for the treatment of solid tumors, including colorectal, non-small cell lung, pancreatic, and breast; and PD-L1 ISAC, a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker to target both tumor and immune cells for the treatment of tumor regression and immunological memory. The company has collaboration agreements with Toray Industries, Genmab A/S, and Innovent Biologics, Inc.; and a license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Redwood City, United States
設立
2026
Bolt Biotherapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker BOLT. The last closing price for Bolt Biotherapeutics was US$4.62. Over the last year, Bolt Biotherapeutics shares have traded in a share price range of US$ 3.91 to US$ 7.35.

Bolt Biotherapeutics currently has 1,921,567 shares in issue. The market capitalisation of Bolt Biotherapeutics is US$8.51 million. Bolt Biotherapeutics has a price to earnings ratio (PE ratio) of -0.28.

BOLT 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.74-14.31334622825.175.384.43124754.65926605CS
4-0.24-5.13918629554.675.74.2501261414.78598792CS
12-0.01-0.2252252252254.445.744.03240214.81148274CS
26-1.36-23.48877374785.797.19993.91259715.15806766CS
52-2.92-39.72789115657.357.353.91275185.32645346CS
1562.83176.8751.67.350.261234771.0838808CS
260-12.42-73.709198813116.8519.2850.261703223.08494514CS

BOLT - Frequently Asked Questions (FAQ)

What is the current Bolt Biotherapeutics Inc share price?
The current share price of Bolt Biotherapeutics Inc is US$ 4.43
How many Bolt Biotherapeutics Inc shares are in issue?
Bolt Biotherapeutics Inc has 1,921,567 shares in issue
What is the market cap of Bolt Biotherapeutics Inc?
The market capitalisation of Bolt Biotherapeutics Inc is USD 8.51M
What is the 1 year trading range for Bolt Biotherapeutics Inc share price?
Bolt Biotherapeutics Inc has traded in the range of US$ 3.91 to US$ 7.35 during the past year
What is the PE ratio of Bolt Biotherapeutics Inc?
The price to earnings ratio of Bolt Biotherapeutics Inc is -0.28
What is the cash to sales ratio of Bolt Biotherapeutics Inc?
The cash to sales ratio of Bolt Biotherapeutics Inc is 1.35
What is the registered address of Bolt Biotherapeutics Inc?
The registered address for Bolt Biotherapeutics Inc is 900 Chesapeake Drive, Redwood City, California, 94063
What is the Bolt Biotherapeutics Inc website address?
The website address for Bolt Biotherapeutics Inc is www.boltbio.com
Which industry sector does Bolt Biotherapeutics Inc operate in?
Bolt Biotherapeutics Inc operates in the Biotechnology & Life Sciences sector

BOLT 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

BOLT Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock